Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 21 min ago
Peer-reviewedCC BY-NC 4.0Science Advances

Genetic dissection of cell type–specific congenital heart disease variants reveals ETS1 control of vascular smooth muscle cell fate

6 affiliations
  1. 1Department of Cardiology, Heart Center, Zhujiang Hospital, Southern Medical University, 253 Industrial Avenue, Guangzhou 510280, China.
  2. 2Affiliated Hospital, Guangdong Medical University, Renmin Road South, Xiashan District, Zhanjiang 524001, Guangdong, China.
  3. 3Department of Physiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
  4. 4Department of Cardiology, Heart Center, First People’s Hospital of Shunde, Southern Medical University, Shunde District, Foshan 528300, China.
  5. 5School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
  6. 6Institute of Molecular Medicine, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 10087, China.

Abstract

Numerous congenital heart disease (CHD) risk variants lie in cis-regulatory elements, yet the impact of variants in repressed and bivalent chromatin on cell type–specific heart development is unclear. Here, we generated a single-cell multiomic atlas of human cardiac differentiation by jointly profiling H3K27ac, H3K27me3, H3K4me3, and transcriptomes in individual cells, classifying cis-regulatory elements into six chromatin states, enabling prioritization of 610 CHD-associated noncoding variants enriched in lineage- and state-specific regulatory elements, including repressive and bivalent regions. CRISPR knockin of selected variants perturbed nearby gene expression and impaired cardiac differentiation. Dissection of a Polycomb-marked variant near ETS1 (ETS proto-oncogene 1) revealed local H3K27me3 loss, H3K27ac gain, and ETS1 up-regulation, which redirects differentiation toward second-heart-field progenitors with epithelial characteristics at early stages and, ultimately, highly migratory ETS1+ vascular smooth muscle cells. Together, our work establishes a single-cell chromatin-state framework for interpreting noncoding CHD risk variants and uncovers an ETS1-driven program linking Polycomb-deregulated noncoding variation to aberrant vascular smooth muscle fate commitment during human cardiogenesis.

Related

  1. Genetic variants associated with cell-type-specific intra-individual gene expression variability reveal mechanisms of genome regulation
    Angli Xue, Seyhan Yazar, José Alquicira-Hernández +7
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full text1 citedGenetics & genomicsPMC
  2. Genetic divergence between reservoir and pre-therapy plasma HIV-1 Env variants does not confer consistent compartment-specific differences in broadly neutralizing antibody sensitivity
    Siyamthemba Dlamini, Doty Ojwach, Jennifer Giandhari +4
    Journal of VirologyPeer-reviewedCC BY 4.0Full textMicrobiologyPMC
  3. Unravelling the role of IRX4 variants in non-syndromic and Down syndrome associated congenital heart disease
    J. Maddhesiya, K. Jain, D. Jain +3
    bioRxivPreprintAll rights reservedFull textGenetics & genomicsbioRxiv
  4. ALG14 Variants Contribute to a Congenital Disorder of Glycosylation Characterized by Congenital Myasthenia and Epilepsy
    Jonathan Marquez, Flavien Rouxel, Fatima It +35
    Human Genetics and Genomics AdvancesPeer-reviewedCC BY 4.0Full textDevelopmental biologyGenetics & genomicsHAL
  5. Haplotype-resolved genetic mapping using selfed progeny enables simultaneous genome assembly validation and trait dissection in a heterozygous plant
    I. Lim, S. H. Lee, W. Cho +4
    bioRxivPreprintAll rights reservedFull textGenetics & genomicsbioRxiv
BibTeX
@article{li2026genetic,
  title = {{Genetic dissection of cell type–specific congenital heart disease variants reveals ETS1 control of vascular smooth muscle cell fate}},
  author = {Xin Li and Mingzhu Fu and Shengtao Jia and Zhenwei Wu and Long Pang and Ke Xiong and Yujun Wang and Wen Li and Aibin He and Shanshan Ai},
  journal = {Science Advances},
  year = {2026},
  month = nov,
  doi = {10.1126/sciadv.aeg4687},
  url = {https://www.science.org/doi/abs/10.1126/sciadv.aeg4687},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Genetic dissection of cell type–specific congenital heart disease variants reveals ETS1 control of vascular smooth muscle cell fate
AU  - Xin Li
AU  - Mingzhu Fu
AU  - Shengtao Jia
AU  - Zhenwei Wu
AU  - Long Pang
AU  - Ke Xiong
AU  - Yujun Wang
AU  - Wen Li
AU  - Aibin He
AU  - Shanshan Ai
PY  - 2026
DA  - 2026/11/04
JO  - Science Advances
DO  - 10.1126/sciadv.aeg4687
UR  - https://www.science.org/doi/abs/10.1126/sciadv.aeg4687
AB  - Numerous congenital heart disease (CHD) risk variants lie in cis-regulatory elements, yet the impact of variants in repressed and bivalent chromatin on cell type–specific heart development is unclear. Here, we generated a single-cell multiomic atlas of human cardiac differentiation by jointly profiling H3K27ac, H3K27me3, H3K4me3, and transcriptomes in individual cells, classifying cis-regulatory elements into six chromatin states, enabling prioritization of 610 CHD-associated noncoding variants enriched in lineage- and state-specific regulatory elements, including repressive and bivalent regions. CRISPR knockin of selected variants perturbed nearby gene expression and impaired cardiac differentiation. Dissection of a Polycomb-marked variant near ETS1 (ETS proto-oncogene 1) revealed local H3K27me3 loss, H3K27ac gain, and ETS1 up-regulation, which redirects differentiation toward second-heart-field progenitors with epithelial characteristics at early stages and, ultimately, highly migratory ETS1+ vascular smooth muscle cells. Together, our work establishes a single-cell chromatin-state framework for interpreting noncoding CHD risk variants and uncovers an ETS1-driven program linking Polycomb-deregulated noncoding variation to aberrant vascular smooth muscle fate commitment during human cardiogenesis.
SN  - 2375-2548
ER  -